Clinical Trial Update: Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study evaluating nimotuzumab in combination with neoadjuvant and concurrent chemoradiotherapy for oropharyngeal and hypophar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopharyngeal Cancer
• Oropharyngeal Cancer

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: The Second People's Hospital of Sichuan | Conditions: Oropharyngeal Cancer, Hypopharyngeal Cancer | Phase 2 | Status: UNKNOWN